Dog Driven Podcast

← Dog Driven Podcast27 Jul · 21 min

Myth Buster Monday: Is Glucosamine Worth Buying?

Myth Buster Monday: Is Glucosamine Worth Buying?27 Jul21 min

<p>Walk into any pet store and you&#39;ll find shelves lined with joint supplements promising to keep your dog active for years to come—but is glucosamine really worth the investment?</p><p>In this episode of <strong>Myth Buster Monday</strong>, we&#39;re separating marketing from medicine. We&#39;ll break down what glucosamine actually does, what the current research says, and which dogs are most likely to benefit. You&#39;ll learn why glucosamine isn&#39;t a cure for arthritis, why product quality matters, and how to set realistic expectations if you&#39;re considering adding it to your dog&#39;s routine.</p><p>We&#39;ll also dive into why joint health is about far more than a single supplement. From maintaining a healthy body condition and therapeutic omega-3 fatty acids to advanced therapies like <strong>Adequan</strong> and <strong>platelet-rich plasma (PRP)</strong>, we&#39;ll discuss how veterinarians build comprehensive, evidence-based plans to help protect joints, improve mobility, and keep canine athletes performing at their best.</p><p>Whether you have a senior companion, a hunting partner, or a competitive performance dog, this episode will help you make more informed decisions about supporting your dog&#39;s long-term joint health.</p><p><strong>In this episode, you&#39;ll learn:</strong></p><ul><li>What glucosamine is—and what it isn&#39;t</li><li>What the science says about oral joint supplements</li><li>Which dogs are most likely to benefit</li><li>Why weight management remains one of the most effective joint therapies</li><li>How Adequan works and why it&#39;s considered a cornerstone disease-modifying therapy for osteoarthritis</li><li>What PRP therapy is and when it may be beneficial</li><li>How to build a comprehensive joint health strategy with your veterinarian</li></ul><p>Because when it comes to protecting your dog&#39;s joints, the best plan isn&#39;t built around one product—it&#39;s built around evidence.</p><p></p>